Metabolic markers of stress-induced myocardial ischemia
- PMID: 2022052
Metabolic markers of stress-induced myocardial ischemia
Abstract
The human heart in the fasting state extracts free fatty acids (FFA), glucose, lactate, pyruvate, and ketones from circulating blood. The utilization of FFA accounts for most of the oxygen consumed and energy produced at rest. Patients with angiographically demonstrable coronary artery disease and stable angina pectoris have a resting myocardial metabolism similar to that of normal individuals. During atrial pacing in normal persons, there is a significant enhancement of glucose uptake but that of FFA is unchanged, and the oxidation of carbohydrates accounts for more than 60% of the energy produced. In patients with stable angina, myocardial perfusion becomes regionally inadequate during stress. Despite the increase of myocardial glucose utilization, carbohydrate oxidation is negligible. Pyruvate will not be oxidized but in the presence of increased amounts of reduced coenzymes will be reduced to lactate. In addition, a greater amount of alanine will be released by the myocardium through the transamination of pyruvate, with a concomitantly greater uptake of glutamate that serves as the NH2 donor. In addition, glutamate may be used as an anaerobic fuel through conversion to succinate coupled with GTP formation. Although coronary hemodynamics, including myocardial perfusion, return to baseline within a few minutes after stress, a longer time course is needed for myocardial metabolism to become normal. In particular, myocardial utilization of exogenous glucose remains higher well after the normalization of hemodynamic parameters. This is more pronounced in postischemic myocardium, but it also occurs in nonischemic muscle, and glucose is presumably used for rebuilding glycogen stores that were depleted during ischemia.
Similar articles
-
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography.Prog Cardiovasc Dis. 1989 Nov-Dec;32(3):217-38. doi: 10.1016/0033-0620(89)90027-3. Prog Cardiovasc Dis. 1989. PMID: 2682779 Review.
-
Myocardial substrate utilization and amino acid metabolism in chronic coronary artery disease.Z Kardiol. 1987;76 Suppl 5:19-25. Z Kardiol. 1987. PMID: 3433881
-
[Reduced myocardial fatty acid utilization in coronary heart disease following symptom limited ergometric stress. Detection of pathologic metabolic patterns using iodine-123-phenylpentadecanoic acid and sequential SPECT].Z Kardiol. 1989 Apr;78(4):262-70. Z Kardiol. 1989. PMID: 2786661 German.
-
[Planar scintigraphy versus PET in measuring fatty acid metabolism of the heart].Herz. 1987 Feb;12(1):41-50. Herz. 1987. PMID: 3493962 German.
-
Metabolic therapy for patients with diabetes mellitus and coronary artery disease.Am J Cardiol. 2006 Sep 4;98(5A):14J-18J. doi: 10.1016/j.amjcard.2006.07.004. Epub 2006 Jul 24. Am J Cardiol. 2006. PMID: 16931201 Review.
Cited by
-
Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease.J Nucl Cardiol. 1994 Mar-Apr;1(2 Pt 2):S34-9. doi: 10.1007/BF02940067. J Nucl Cardiol. 1994. PMID: 9420696 Review.
-
Metabolic risk factors associated with sudden cardiac death (SCD) during acute myocardial ischemia.Forensic Sci Res. 2017 Jul 6;2(3):126-131. doi: 10.1080/20961790.2017.1343269. eCollection 2017. Forensic Sci Res. 2017. PMID: 30483630 Free PMC article.
-
Narrative review of metabolomics in cardiovascular disease.J Thorac Dis. 2021 Apr;13(4):2532-2550. doi: 10.21037/jtd-21-22. J Thorac Dis. 2021. PMID: 34012599 Free PMC article. Review.
-
Clinical usefulness of iodine 123-labeled fatty acid imaging in patients with acute myocardial infarction.J Nucl Cardiol. 1998 May-Jun;5(3):275-84. doi: 10.1016/s1071-3581(98)90129-5. J Nucl Cardiol. 1998. PMID: 9669582
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources